Phase IV Study of Concomitant Administration of the sIPV and HepA

Conditions

• Polio
• Hepatitis A

Interventions

• BIOLOGICAL: sIPV (booster dose at 18 months of age)
• BIOLOGICAL: HepA-L
• BIOLOGICAL: HepA-I

Sponsor

Institute of Medical Biology, Chinese Academy of Medical Sciences